
|Articles|April 1, 2004
Supplements and Featured Publications
- Newsletter - Inflammation, Metabolic Syndrome, and CV Risk Reduction
- Volume 10
- Issue 1 Metab
Inflammation, Metabolic Syndrome, and CV Risk Reduction
Advertisement
Articles in this issue
over 21 years ago
Traditional CV risk factors: Necessary, but are they sufficient?Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients
2
Price Transparency With Gaps: Assessing the Completeness of Payer Transparency in Coverage Data
3
Adolescents Saw Mental Health Gains After School Reopened Post Pandemic
4
Camizestrant-Related Photopsia Mostly Mild, Nondisabling in Patients With Advanced Breast Cancer: Adam Brufsky, MD, PhD
5













































